Comparison of a new oral drug (ivermectin) with 5% topical permethrin lotion (conventional drug) for treament of scabies in children (1-12 years)

Oral ivermectin vs topical 5% permethrin for management of scabies in children - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055910

Enrollment

710

Registered

2023-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B86- Scabies

Interventions

Intervention1: Oral ivermectin: Single dose ivermectin tablet, 200 microgram/kg Control Intervention1: 5% permethrin lotion: THe lotion was applied over whole body (neck to toe) and kept for 8 hours.

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 1-12 years and presented with scabies

Exclusion criteria

Exclusion criteria: Complicated scabies, On other treatment before presentation, Immunocompromised, allergy to any of the drug under study.

Design outcomes

Primary

Measure	Time frame
Clinical cureTimepoint: 1st, 2nd, 3rd & 4th weeks	—

Secondary

Measure	Time frame
Adverse effectsTimepoint: 1st, 2nd , 3rd & 4th weeks;Clinical gradeTimepoint: 1st, 2nd, 3rd & 4th week;PruritusTimepoint: 1st, 2nd, 3rd & 4th weeks	—

Countries

India

Contacts

Public ContactDr Kamirul Islam

Burdwan Medical College

sudiptopaul165854@gmail.com9475501788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026